FCFrancisca Cantudo

Francisca Cantudo

*This is an algorithmically generated author record based on publicly available information.

Francisca Cantudo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Experience of Using an App in HIV Patients Older Than 60 Years: Pilot Program

    by Julián Olalla, Jose María García de Lomas, Efrén Márquez, Francisco Jesús González, Alfonso Del Arco, Javier De La Torre, Jose Luis Prada, Francisca Cantudo, María Dolores Martín, Miriam Nieto, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The elderly HIV patient population not only presents more comorbidity and poly-medication, but also suffers from stigmatization on behalf of society and lack of social support, where new technologies can now play a role towards enhancing the empowerment of these patients. Objective: To encourage a greater knowledge about the infection, promote patient treatment adherence and offer them the possibility of anonymously establishing contact between them and their peers. Methods: A series of clinical and psychosocial parameters were studied in 30 HIV-infected patients of over 60 years of age. 15 of them were randomized to use an app and 15 were the control group. All tests were repeated after 6 months. Results: The median age of patients was 66,5 years old, with an 11-year period suffering from HIV infection. 29 of them had an undetectable viral load and CD4 nadir was 194 cel/micromole. Median number of comorbidity diseases was 2. 11 of them lived with their parents and 19 lived alone. They spent an average of 5 hours a day sitting down and 56,7% of them referred high physical activity. They scored 4 out of 5 for general quality of life perception. 80% presented high adherence to their treatment and average number of concomitant medication was 5. In the 6-minute walking test (6MWT) they covered a distance of 400 meters and 3 of them desaturated during the test. The 15 patients made frequent use of the app with 2407 sessions and an average of 7 minutes and 56 seconds time of use with a total of 13143 screen views. During the 6 months of the trial, 3 non-AIDS events took place. There were no significant modifications to BMI, blood pressure measurements, lipid profile or panel or immuno-virology information data. Neither was there any significant modification in the distance covered in the 6MWT or of the desaturation percentage. There wasn´t any differences in the questionnaire scores for perception of quality of life either, or for confessed physical activity or ART and non-ART treatment adherence. Conclusions: Significant differences between studied parameters were not objectified in these patients, although this trial has a small sample size and only a brief follow-up period is considered. However, patients did make a frequent use of the app, making this a possible method of intervention to be proposed in future subsequent studies


  • Open Access

    Experience of Using an App in HIV Patients Older Than 60 Years: Pilot Program (Preprint)

    by Julián Olalla, Jose María García de Lomas, Efrén Márquez, Francisco Jesús González, Alfonso Del Arco, Javier De La Torre, Jose Luis Prada, Francisca Cantudo, María Dolores Martín, Miriam Nieto, et al.

    BACKGROUND New technologies can promote knowledge of HIV infection among patients suffering from this disease. Older patients with HIV infection represent an increasingly large group that could benefit from the use of specific apps. OBJECTIVE The aim of the study was to observe the acceptability and use of a mobile app on HIV infection in patients at least 60 years old and offer them the possibility of anonymously establishing contact with their peers. METHODS A series of clinical and psychosocial parameters were studied in 30 HIV-infected patients of over 60 years. The patients must be at least 60 years old, with a follow-up in the outpatient clinic for at least 1 year and without pathologies that limit his or her life expectancy to less than a year. They must know how to read and write. To be part of the group assigned to the app, they had to have their own smartphone and confirm that they were connected to the internet from that device. Overall, 15 of them were randomized to use an app and 15 were in the control group. All tests were repeated after 6 months. RESULTS The median age of patients was 66.5 years. Among them, 29 patients had an undetectable viral load at baseline. The median number of comorbid diseases was 2. Overall, 11 of them lived with their partners and 19 lived alone. They spent an average of 5 hours a day sitting down, and 56% (17/30) of them referred high physical activity. They scored 4 out of 5 for general quality of life perception. Moreover, 80% (24/30) presented high adherence to their treatment, and the average number of concomitant medications was 5. In the 6-min walking test, they covered a distance of 400 meters, and 3 of them desaturated during the test. The 15 patients made frequent use of the app, with 2407 sessions and an average of 7 min and 56 seconds time of use with a total of 13,143 screen views. During the 6 months of the trial, 3 non-AIDS events took place. There were no significant modifications to body mass index, blood pressure measurements, lipid profile, or immuno-virology information data. There were no differences in the questionnaire scores for perception of quality of life, confessed physical activity, or antiretroviral treatment (ART) and non-ART treatment adherence. CONCLUSIONS Significant differences between studied parameters were not objectified in these patients, possibly because this trial has significant limitations, such as a small sample size and only a brief follow-up period. However, patients did use the app frequently, making this a possible intervention to be proposed in future subsequent studies.